+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Radiopharmaceutical"

Positron Emission Tomography (PET) Nuclear Medicine Market 2024 - Product Thumbnail Image

Positron Emission Tomography (PET) Nuclear Medicine Market 2024

  • Report
  • December 2024
  • 175 Pages
  • Global
From
Medical Isotopes Global Market Report 2024 - Product Thumbnail Image

Medical Isotopes Global Market Report 2024

  • Report
  • July 2024
  • 175 Pages
  • Global
From
From
Nuclear Medicine Market 2024-2028 - Product Thumbnail Image

Nuclear Medicine Market 2024-2028

  • Report
  • July 2024
  • 177 Pages
  • Global
From
From
From
From
From
From
From
Radiopharmaceuticals Global Market Report 2024 - Product Thumbnail Image

Radiopharmaceuticals Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
From
Loading Indicator

Radiopharmaceuticals are a type of biopharmaceutical used in medical imaging and therapy. They are typically composed of a radioactive isotope, such as technetium-99m, bound to a biologically active molecule, such as a peptide or antibody. Radiopharmaceuticals are used to diagnose and treat a variety of diseases, including cancer, cardiovascular disease, and neurological disorders. They are administered intravenously, orally, or by inhalation, depending on the type of radiopharmaceutical and the desired therapeutic effect. The radiopharmaceutical market is a rapidly growing segment of the biopharmaceutical industry. It is driven by advances in medical imaging technology, the development of new radiopharmaceuticals, and the increasing prevalence of diseases that can be treated with radiopharmaceuticals. Some of the major companies in the radiopharmaceutical market include GE Healthcare, Mallinckrodt Pharmaceuticals, Bracco Imaging, and Lantheus Medical Imaging. Show Less Read more